Recently seen in news, 2-deoxy-D-glucose (2-DG) drug has been developed by
A. University of Oxford
B. Bharat Biotech
C. Johnson & Johnson
D. INMAS-DRDO
Explanation:
The Drugs Controller General of India (DCGI) has granted permission for emergency use of anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) developed by INMAS, DRDO. The Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s Laboratories (DRL),Hyderabad.
